Re:Undisclosed financial conflicts of interest in DSM-5 (2024)
by nullc on Tuesday August 26, 2025 @07:41PM
(#45033710)
I dunno that we disagree. My point was just that its easier to put a finger on the scale when any improvement, non-improvement, or even the existence of a disease itself is more subjective.
Like, we can't sell treatment's for people's sixth thumbs because virtually no people have a sixth thumb and it's unambiguous that they don't-- and even among any who do it'll probably be clear if it needs treating or not. But I can sell a treatment for your hyper-meta-ego because who is to say if a person has one of those or not or if my treatment of it is successful or not?
If there is money to be made the medical establishment will put much more effort into that area than if there is not
Bringing it back to the DSM: The more human states of mind that can be classified as a "psychiatric illness" the more money there is to be made in marketing various therapies
This is glaringly obvious in drug development but it applies to all forms of therapy that can be done in a way with a gate keeper who can charge a toll